All the Active Ingredient Drugs
5-HT1 Agonist. Sumatriptan (as succinate) 50 mg, 100 mg. TABS: 2, 6 x 50 mg, 100 mg. 1 tab of 50
mg. Some pts. may require 1 tab of 100
mg. If sympt. recur: 1 tab. aft. at least 2
hrs. Pts. who fail to respond initially
should not receive second dose for
same attack. Max. dose: 3 tabs (300
mg) in 24 hrs.
Acute relief of migraine attacks, with or
w/o aura, should only be used where there
is a clear diagnosis of migraine.
C/I: Hypersens.; Pts. with hist. of MI or
have ischaem. heart dis., coron.
vasospasm (Prinzmetal’s ang.), periph. vasc. dis. or sympt. or signs consistent
with ischaem. heart dis.;
Pts. with a hist. of CVA or TIA; Pts. with
severe hep. impair.; Pts. with moder./
severe HTN. and mild uncontrol. HTN;
concom. admin.of ergotamine, or
derivate. of ergotamine (includ.
methysergide) or any triptan/5-HT1
receptor agon.; Concur. admin. with
MAOIs. Must not be used within 2 wks.
of discount. of ther. with MAOIs.
5-HT1 Agonist. Sumatriptan (as succinate) 6 mg / 0.5 ml. PREFILL. SYRINGE: 2 x 6 mg / 0.5 ml
(incl. 1 auto-injector). 1 inject. S.C. If
sympt. recur in pt. who responds,
another inject. any time within next 24
hrs., but not less than 1 hr. aft. prev.
inject. Max. dose: 2 injects. (12 mg) in
24 hrs. Pts. who fail to respond initially
should not receive second dose for
same attack.
Acute relief of migraine attacks with or
w/o aure, cluster headache. For the acute
tmt. of migraine attacks assoc. with
women’s menstr. cycle.
5-HT1 Agonist. Sumatriptan 20 mg / 0.1 ml. NASAL SPR.: 2 x 20 mg/0.1 ml. 1 x 2.
Up to 2 sprays in 24 hrs.
Acute tmt. of migraine attacks with or w/o
aura.
C/I: Hypersens.; Pts. with hist. of MI or
have ischaem. heart dis., coron.
vasospasm (Prinzmetal’s ang.), periph.
vasc. dis. or sympt. or signs consistent
with ischaem. heart dis.; Pts. with a hist. of CVA or TIA; Pts. with
severe hep. impair.; Pts. with moder./
severe HTN. and mild uncontrol. HTN;
concom. admin.of ergotamine, or
derivate. of ergotamine (includ.
methysergide) or any triptan/5-HT1
receptor agon.; Concur. admin. with
MAOIs. Must not be used within 2 wks.
of discount. of ther. with MAOIs.
5-HT1 Agonist. Sumatriptan (as succinate) 50 mg, 100 mg. CAPLETS: 2, 6 x 50mg, 100mg. Adults 18-65 yrs: 1 caplet of 50 mg. Some pts. May require 1 caplet of 100 mg. If sympt. recur: 1 caplet. aft. At least 2 hrs. Pts. who fail to respond initially should not receive second dose for same attack. Max. dose: 300 mg in 24 hrs.
Acute relief of migraine attacks, with or without aura, should only be used where there is a clear diagnosis of migraine.
C/I: Hypersens.; Pts. with hist. of MI or have ischaem. heart. dis., coron. vasospasm (Prinzmetal’s ang.), periph. vasc. dis. or sympt. or signs consistent with ischaem. heart dis.; Pts. with a hist. of CVA or TIA; Pts. with severe hep. impair.; Pts. with moder./severe HTN. and mild uncontrol. HTN; concom. admin. of ergotamine, or derivate. of ergotamine (include. methysergide) or any triptan/5-HT1 receptor agon.; Concur. admin. with MAOIs. Must not be used within 2 wks. of discont. of ther. with MAOIs. See lit.